Biological Function of Dreaming in Dreaming and Non-Dreaming Patients With PCA Infarction
NCT ID: NCT04749992
Last Updated: 2024-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
142 participants
OBSERVATIONAL
2018-08-01
2024-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
NCT04096261
Chronic Sleep Restriction
NCT01493661
Autonomic Mechanisms of Sleep-dependent Memory Consolidation
NCT04021797
Sleep and Memory in Children
NCT02785328
Does Acoustic Stimulation During Sleep Boost Slow Wave Sleep and Memory Performance?
NCT04277104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Why do dreams occupy such a significant part of human life? What is the biological function of dreams? The physiological function of dreaming for humans has been investigated in extensive studies. However, these are predominantly in the area of memory research and address the question of whether dreaming is conducive to memory consolidation. However, other biological functions of dreaming, such as their influence on the restorative effects of sleep, remain virtually unexplored to date. Therefore, the planned DFG (Deutsche Forschungsgemeinschaft) study will investigate the effect of dream activity on the objective and subjective quality of sleep.
Solms was able to show that damage to the parieto-occipital brain region leads to a complete loss of dream recall in a large number of clinical cases (in 44 of 361 cases). This discovery holds the possibility of relating the biological function of dreaming to neuroanatomical structures. Obviously, the loss of dream memory must be related to the specific damage of the brain, or its biological functions.
Further studies also show that acute thrombotic infarction of the occipital lobe in the current area of the posterior cerebral artery can lead to complete loss of dream activity with simultaneous maintenance of REM sleep. The authors Bischof \& Bassetti noticed, seemingly by chance and without grasping the theoretical implications of the discovery, that their patient was suffering from insomnia with difficulty falling asleep and staying asleep.
Based on these observations, Solms conducted a pilot study comparing the sleep patterns of five dreaming and five nondreaming patients with thrombotic infarcts in the same arterial territory-as observed by Bischof \& Bassetti . Solms and his research group observed that within the non-dreaming group there was a striking decrease in absolute sleep duration, as well as a more frequent number of nocturnal awakenings, more arousals, as well as microarousals (previously unpublished data).
The study of populations that have forfeited the ability to dream with preserved REM sleep makes it possible to test not only the classical theory on the function of dreams, but also such theories that deal with the role of dreams in memory consolidation during sleep. In recent years, there has been increased interest in the hypothesis that sleep contributes to and significantly influences memory processing.
In this context, dreaming is postulated to play a specific role in memory processing during sleep.
There are several hypotheses regarding the role of dreaming in memory consolidation. For example, Stickgold et al. found that during REM sleep, limbic forebrain structures are activated along with the amygdala, while there is concomitant inhibition of hippocampal signalling, which presumably prevents re-activation of episodic memory content. Accordingly, dreams would mainly occur via weak neocortical associations available during REM sleep. The authors hypothesize that this feature reflects the brain's attempts to recognize and evaluate new cortical associations in the context of emotions mediated by limbic structures. They concluded that one function of REM sleep was to enhance or attenuate specifically activated associations with regression to pictorial imaginings to compensate for the relative loss of motor activity during sleep.
Similarly, it has been postulated that the occurrence of memories in dreams promotes learning by, first, reactivating memory elements in their original perceptual state and, second, that linking a wide variety of memory elements strengthens and consolidates them and, third, that dreaming newly learned material facilitates later recall.
Relevance and research questions of the study:
Through a specific choice of sample of neurological patients with posterior cortical lesions who are at risk of losing the ability to dream due to the lesion, the proposed project is particularly aimed at understanding the biological function of dreaming as distinct from REM sleep. Based on the neuropsychoanalytic theory of Solms, as well as neuropsychological findings that REM sleep and dreaming are doubly dissociable phenomena, the central hypothesis that dreams serve to maintain sleep (Sigmund Freud's hypothesis) will be investigated. By this, Freud meant that dreams serve to respond to sometimes highly affect-laden impulses to action with hallucinatory wish fulfillment, so that they do not lead to premature awakening. Secondly, it will be investigated whether dreams influence affective memory consolidation. This will be investigated using two groups of neurological patients with thrombotic infarction in the posterior stream area, i.e., the posterior cerebral artery (PCA infarction) during preserved REM sleep (i) who have lost the ability to recall dreams, and (ii) in whom the ability to recall dreams has been preserved. This has far-reaching implications not only for sleep medicine and neuroscience, but also for clinical neurology. Sleep pathologies have not yet been considered clinically-scientifically as a consequence of PCA infarction and, accordingly, have not yet been studied, but could provide significant clues for the clinical management of such patients. Similarly, findings on memory consolidation after PCA infarction during preserved REM sleep are significant because an important aspect of memory processing during sleep is examined with the distinction between preserved and nonsustained dreaming, which also has not been considered in scientific studies to date but is of clinical relevance.
Hypotheses Our hypotheses are that patients who have lost the ability to dream during preserved REM sleep will have (i) poorer sleep quality and (ii) poorer emotional declarative memory and non-declarative motor memory consolidation.
Non-dreamers vs. dreamers.
Null hypothesis (H0):
There is no difference in terms of loss of ability to dream during preserved REM sleep, related to poorer sleep quality, as well as poorer emotional declarative and non-declarative motor memory consolidation between the experimental group and the comparison group
Alternative hypothesis (H1):
There is a difference in loss of ability to dream with preserved REM sleep related to worse sleep quality and worse emotional declarative and non-declarative motor memory consolidation between experimental group and comparison group
Design
Prospective two-arm controlled observational study (quasi-experimental between-group design).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-Dreamers
Experimental Group
Polysomnographic examination in sleep laboratory (PSG measurement)
Recording of sleep quality and quantity by sleep parameters, such as total sleep time - TST; duration of sleep stages - S1t, S2t, S3t, rapid eye movement - REMt; sleep onset latency - SL; wake after sleep onset - WASO, sleep efficiency - SE.
Dreamers
Comparison Group
Polysomnographic examination in sleep laboratory (PSG measurement)
Recording of sleep quality and quantity by sleep parameters, such as total sleep time - TST; duration of sleep stages - S1t, S2t, S3t, rapid eye movement - REMt; sleep onset latency - SL; wake after sleep onset - WASO, sleep efficiency - SE.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polysomnographic examination in sleep laboratory (PSG measurement)
Recording of sleep quality and quantity by sleep parameters, such as total sleep time - TST; duration of sleep stages - S1t, S2t, S3t, rapid eye movement - REMt; sleep onset latency - SL; wake after sleep onset - WASO, sleep efficiency - SE.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dream recall before infarction more than 1 dream/week
* REM sleep present
* Willingness of the patient to participate in the sleep laboratory examinations within the scope of the study or to fill in questionnaires/diaries.
* Patient is cognitively and linguistically able to comprehend the meaning of the study
* Existence of a written declaration of consent
Exclusion Criteria
* Diagnosis of any previously known sleep disorder confounding with the study results, recorded on 1st screening night (sleep laboratory)
1. severe insomnia
2. Restless Leg Syndrome (RLS)
3. periodic movements of the extremities during sleep (PLMS), and
4. obstructive sleep apnea syndrome (OSAS)
* Diagnosis of any neurological or psychiatric disorders or other conditions that may conflict with the study results
* Cerebral insults in areas outside the posterior cerebral artery (excluding small vessel disease)
* Medication use affecting sleep architecture, such as benzodiazepines, anticonvulsants, SSRIs.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
International Psychoanalytic University Berlin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tamara Fischmann
Professor for clinical psychology and psychoanalysis
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamara Fischmann, Prof.
Role: PRINCIPAL_INVESTIGATOR
International Psychoanalytic University
Michael Koslowski, Dr.
Role: PRINCIPAL_INVESTIGATOR
Charite university medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite university medicine
Berlin, , Germany
International Psychoanalytic University
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wamsley EJ, Tucker M, Payne JD, Benavides JA, Stickgold R. Dreaming of a learning task is associated with enhanced sleep-dependent memory consolidation. Curr Biol. 2010 May 11;20(9):850-5. doi: 10.1016/j.cub.2010.03.027. Epub 2010 Apr 22.
Pace-Schott EF, Hobson JA. The neuropsychology of dreams: a clinico-anatomical study. Trends Cogn Sci. 1998 May 1;2(5):199-200. doi: 10.1016/s1364-6613(98)01166-8.
Bischof M, Bassetti CL. Total dream loss: a distinct neuropsychological dysfunction after bilateral PCA stroke. Ann Neurol. 2004 Oct;56(4):583-6. doi: 10.1002/ana.20246.
Rasch B, Born J. About sleep's role in memory. Physiol Rev. 2013 Apr;93(2):681-766. doi: 10.1152/physrev.00032.2012.
Stickgold R, Hobson JA, Fosse R, Fosse M. Sleep, learning, and dreams: off-line memory reprocessing. Science. 2001 Nov 2;294(5544):1052-7. doi: 10.1126/science.1063530.
Payne JD, Nadel L. Sleep, dreams, and memory consolidation: the role of the stress hormone cortisol. Learn Mem. 2004 Nov-Dec;11(6):671-8. doi: 10.1101/lm.77104.
Nielsen TA, Stenstrom P. What are the memory sources of dreaming? Nature. 2005 Oct 27;437(7063):1286-9. doi: 10.1038/nature04288.
Walker MP, Brakefield T, Hobson JA, Stickgold R. Dissociable stages of human memory consolidation and reconsolidation. Nature. 2003 Oct 9;425(6958):616-20. doi: 10.1038/nature01930.
Solms M. Dreaming is not controlled by hippocampal mechanisms. Behav Brain Sci. 2013 Dec;36(6):629; discussion 634-59. doi: 10.1017/S0140525X1300143X.
Blake Y, Terburg D, Balchin R, van Honk J, Solms M. The role of the basolateral amygdala in dreaming. Cortex. 2019 Apr;113:169-183. doi: 10.1016/j.cortex.2018.12.016. Epub 2018 Dec 25.
Solms M. Neurobiology and the neurological basis of dreaming. Handb Clin Neurol. 2011;98:519-44. doi: 10.1016/B978-0-444-52006-7.00034-4. No abstract available.
Solms M. Freud returns. Sci Am. 2004 May;290(5):82-8. doi: 10.1038/scientificamerican0504-82. No abstract available.
Freud, S. (1948). Die Traumdeutung.[Erstausgabe 1900]. Freud, Sigmund Gesammelte Werke. Chronologisch geordnet. London: Imago, Bde, 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
InternationalPUB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.